TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI) and global provider of life science ...

Barclays analyst Luke Sergott raised the firm’s price target on Avantor (AVTR) to $26 from $25 and keeps an Overweight rating on the shares.

In a report released today, Luke Sergott from Barclays maintained a Buy rating on Avantor (AVTR – Research Report), with a price target of ...

TriLink BioTechnologies, a Maravai LifeSciences company and provider of life science reagents and services, has partnered ...

Wall Street expects flat earnings compared to the year-ago quarter on lower revenues when Avantor, Inc. (AVTR) reports results for the quarter ended December 2024. While this widely-known consensus ...

RADNOR, PA — Avantor, Inc. (NYSE: AVTR) has announced a definitive agreement to sell its clinical services business to Audax ...

Avantor, Inc. is a life science tools company that engages in providing mission-critical products and services to the life sciences and advanced technology industries. Its portfolio includes ...

Get Our Latest Research Report on Avantor Avantor Trading Down 3.9 % Shares of AVTR stock opened at $21.55 on Thursday. The company has a quick ratio of 1.06, a current ratio of 1.54 and a debt-to ...

Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that it will release ...